References
- Koeffler, H. P. (1996). Myelodysplastic syndromes. Semin Hematol., 33, 87–94.
- Yoshida, Y., Anzai, N. and Kawabata, H. (1995). Apoptosis in myelodysplasia: a paradox or paradigm. Leukemia Res., 19, 887–891.
- Weisdorf, D. J., Oken, M. M., Johnson, G. J. and Rydell, R. E. (1983). Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia. Br. J. Hematology, 55, 691.
- Dunbar, C. E. and Nienhuis, A. W. (1995). Myelodysplastic syndromes. In Blood. Principles and practice of hematology. Ed. by Handin, R. I., Lux, S. E. and Stossel, T. P., J. B. Lippincott Comp, pp. 377–414.
- Dickstein, J. I. and Vardiman, J. W. (1993). Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am. J. Clin. Pathol., 99, 513–525.
- Verhoef, G. E. G., Wolf-Peeters, C. D., Ferrant, A., Deprez, S., Meeus, P., Stul, M., Zachee et al. (1991). Myelodysplastic syndromes with bone marrow fibrosis: myelodysplastic disorder with proliferative features. Ann. Hematol., 63, 235–241.
- Rajapaksa, R., Ginzton, N., Rott, L. S. and Greenberg, P. L. (1996). Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 4275–87.
- Raza, A., Gregory, S. A. and Preisler, H. D. (1996). The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines. Leukemia Res., 20, 881–890.
- Hamblin, T. J. and Osder, D. G. (1987). The myelodysplastic syndrome—a practical guide. Hematol. Oncol., 5, 19–34.
- Lofvenberg, E. and Wahlin, A. (1988). Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea. Eur. J. Hematol., 41, 375–381.
- Donehower, R. C. (1992). An overview of the clinical experience with hydroxyurea. Semin Oncol., 19, 11–19.
- Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Dralnick, H. R. and Sultan, C. (1982). Proposals for the classification of the myelodysplastic syndromes. Br. J. Hematol., 51, 185–199.
- Raza, A., Gezer, S., Mundle, S., Gao, X.-Z., Alvi, S., Borok, R. et al. (1995). Apoptosis in bone marrow samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood, 86, 268–76.
- Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B. and Khan, Z. et al. (1995). Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol., 48, 143–54.
- Lepelley, P., Campergue, L., Grardel, N., Preudhomme, C., Cosson, A. and Fenaux, P. (1996). Is apoptosis a massive process in myelodysplastic syndromes? Br. J. Hematol., 95, 368–71.
- Rajapaksa, R., Ginzton, N., Rott, L. S. and Greenberg, P. L. (1996). Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 4275–87.
- Eckhard, S. G., Dai, A., Davidson, K. K., Forseth, B. J., Wahl, G. M. and Von Hoff, D. D. (1994). Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proc. Natl. Acad. Sci., USA, 91, 6674–78.
- Erard, F., Dean, A. and Schechter, A. N. (1981). Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells. Blood, 58, 1236–39.
- Gomez-Casares, M. T., Delgado, M. D., Lerga, A., Crespo, P., Quincoces, A. F., Richard, C. and Leon, J. (1993). Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells. Leukemia, 7, 1824–33.
- Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L., Dar, S. et al. (1996). Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia Res., 20, 891–900.
- Raza, A., Mundle, S., Shetty, V., Alvi, S., Chopra, H., Span, L. et al. (1996). Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int. J. Hematol., 63, 265–278.